News coverage about Syneron Medical (NASDAQ:ELOS) has trended somewhat positive on Tuesday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Syneron Medical earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 45.5668012578955 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

A number of equities analysts have recently issued reports on the stock. BidaskClub downgraded shares of Syneron Medical from a “hold” rating to a “sell” rating in a report on Thursday, July 6th. Maxim Group downgraded shares of Syneron Medical from a “buy” rating to a “hold” rating and cut their price target for the company from $12.00 to $11.00 in a report on Friday, May 12th.

Shares of Syneron Medical (NASDAQ:ELOS) remained flat at $11.00 during midday trading on Tuesday. 3,905 shares of the stock were exchanged. Syneron Medical has a one year low of $6.18 and a one year high of $11.43. The stock’s 50-day moving average price is $10.90 and its 200 day moving average price is $10.14.

TRADEMARK VIOLATION NOTICE: “Syneron Medical (ELOS) Earning Somewhat Favorable Media Coverage, Study Finds” was reported by Daily Political and is the property of of Daily Political. If you are reading this report on another website, it was copied illegally and reposted in violation of US and international copyright legislation. The correct version of this report can be accessed at

About Syneron Medical

Syneron Medical Ltd. is engaged in the manufacture, research, development, marketing and sale of equipment for the aesthetic medical industry and systems for dermatologists, plastic surgeons and other qualified practitioners. The Company’s aesthetic medical products are based on its various technologies, including Electro-Optical Synergy (ELOS) technology, which uses the synergy between electrical energy, including radiofrequency (RF) energy, and optical energy to provide aesthetic medical treatments.

Insider Buying and Selling by Quarter for Syneron Medical (NASDAQ:ELOS)

Receive News & Ratings for Syneron Medical Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Syneron Medical Ltd. and related companies with's FREE daily email newsletter.